Disorders of phosphate imbalance: a dysregulation of the FGF23 endocrine system

The National Coordinators of EndoERN, BondERN and ERKnet strongly aimed for this multidisciplinary meeting which brings together national and international experts on hypophosphatemia XLH to discuss its management and for its greater dissemination.

July & August newsletter

The July & August-edition of the Endo-ERN newsletter is out now! The call for new members to join the ERN will launch soon, 11 new Affiliated Partners joined the European Reference Network, information about the upcoming events and much more!

Click here for the newsletter

Esta entrada fue publicada el General.

Wolfram syndrome scientific and family meeting in Cardano al Campo (Varese, Italy)

On behalf of the “Associazione Gentian” the “Wolfram Syndrome Italy Association” we cordially invite you to the national scientific and family meeting to be held in Cardano al Campo (Varese, Italy), 21 September 2019. The meeting brings together Italian scientists, families and patients and will be focused on Wolfram syndrome. You will have the unique opportunity to network with colleagues and experts in the field.

Please click here for the program.

 

Webinar «New therapeutic targets for the treatment of pancreatic neuroendocrine»

On Thursday October 10th at 16:00 – 17:00 CET (UK time 15:00 – 16:00) a webinar about the New therapeutic targets for the treatment of pancreatic neuroendocrine will be organized by Jo Blair, Attila Patocs & Rajesh Thakker.

Groningen Pituitary and Skull Base Symposium

From 4 until 6th March 2020, the first Groningen Pituitary and Skull Base Symposium (GPS) to be held in March 2020 in Groningen, the Netherlands.

The GPS symposium is an initiative of two multidisciplinary teams (MDT’s), which are part of the UMC Groningen Comprehensive Cancer Center.
The former Pituitary team and the Skull Base team have merged over the past year into the Groningen Pituitary and Skull Base Center.

For more information please click here

Medical treatment for MCT8 deficiency

Background Deficiency of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) causes severe intellectual and motor disability and high serum tri-iodothyronine (T3) concentrations (Allan–Herndon–Dudley syndrome). This chronic thyrotoxicosis leads to progressive deterioration in bodyweight, tachycardia, and muscle wasting, predisposing affected individuals to substantial morbidity and mortality. Treatment that safely alleviates peripheral thyrotoxicosis and reverses cerebral hypothyroidism is not yet available. We aimed to investigate the effects of treatment with the T3 analogue Triac (3,3′,5-tri-iodothyroacetic acid, or tiratricol), in patients with MCT8 deficiency.

Continuar leyendo

Esta entrada fue publicada el MTG8.

Rare endocrine diseases Padova meeting

On June 7th 2019, in the old Venetian villa Contarini in Piazzola sul Brenta owing to the Venetian Region Counsil, the Endocrinology Unit of Azienda Ospedaliera-University of Padova (director Carla Scaroni, MD ) organized for Endo ERN group of Padova a meeting dedicated to medical doctors involved in child- and adult-hood endocrine rare diseases.

FB_IMG_1562676634516
FB_IMG_1562676631067

The aim of the meeting was to ameliorate the network among different care centers in our territory to uniform the standards of diagnosis and therapy for rare disease patients. Continuar leyendo

Esta entrada fue publicada el General.